These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 36822370)

  • 41. Designing multivalent immunogens for alphavirus vaccine optimization.
    Read CM; Plante K; Rafael G; Rossi SL; Braun W; Weaver SC; Schein CH
    Virology; 2021 Sep; 561():117-124. PubMed ID: 33823988
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The SD1 Subdomain of Venezuelan Equine Encephalitis Virus Capsid Protein Plays a Critical Role in Nucleocapsid and Particle Assembly.
    Reynaud JM; Lulla V; Kim DY; Frolova EI; Frolov I
    J Virol; 2016 Feb; 90(4):2008-20. PubMed ID: 26656680
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The ubiquitin proteasome system plays a role in venezuelan equine encephalitis virus infection.
    Amaya M; Keck F; Lindquist M; Voss K; Scavone L; Kehn-Hall K; Roberts B; Bailey C; Schmaljohn C; Narayanan A
    PLoS One; 2015; 10(4):e0124792. PubMed ID: 25927990
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Old World and New World alphaviruses use different virus-specific proteins for induction of transcriptional shutoff.
    Garmashova N; Gorchakov R; Volkova E; Paessler S; Frolova E; Frolov I
    J Virol; 2007 Mar; 81(5):2472-84. PubMed ID: 17108023
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interplay of acute and persistent infections caused by Venezuelan equine encephalitis virus encoding mutated capsid protein.
    Atasheva S; Krendelchtchikova V; Liopo A; Frolova E; Frolov I
    J Virol; 2010 Oct; 84(19):10004-15. PubMed ID: 20668087
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Artificial microRNAs can effectively inhibit replication of Venezuelan equine encephalitis virus.
    Bhomia M; Sharma A; Gayen M; Gupta P; Maheshwari RK
    Antiviral Res; 2013 Nov; 100(2):429-34. PubMed ID: 23988697
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Structure and Sequence Requirements for RNA Capping at the Venezuelan Equine Encephalitis Virus RNA 5' End.
    Ortega Granda O; Valle C; Shannon A; Decroly E; Canard B; Coutard B; Rabah N
    J Virol; 2021 Jul; 95(15):e0077721. PubMed ID: 34011549
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Analysis of Venezuelan equine encephalitis virus capsid protein function in the inhibition of cellular transcription.
    Garmashova N; Atasheva S; Kang W; Weaver SC; Frolova E; Frolov I
    J Virol; 2007 Dec; 81(24):13552-65. PubMed ID: 17913819
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Homoseongomycin, a compound isolated from marine actinomycete bacteria K3-1, is a potent inhibitor of encephalitic alphaviruses.
    Lin SC; Lehman CW; Stewart AK; Panny L; Bracci N; Wright JLC; Paige M; Strangman WK; Kehn-Hall K
    Antiviral Res; 2021 Jul; 191():105087. PubMed ID: 33965437
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Recombinant sindbis/Venezuelan equine encephalitis virus is highly attenuated and immunogenic.
    Paessler S; Fayzulin RZ; Anishchenko M; Greene IP; Weaver SC; Frolov I
    J Virol; 2003 Sep; 77(17):9278-86. PubMed ID: 12915543
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bivalent single domain antibody constructs for effective neutralization of Venezuelan equine encephalitis.
    Liu JL; Zabetakis D; Gardner CL; Burke CW; Glass PJ; Webb EM; Shriver-Lake LC; Anderson GP; Weger-Lucarelli J; Goldman ER
    Sci Rep; 2022 Jan; 12(1):700. PubMed ID: 35027600
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy of a ML336 derivative against Venezuelan and eastern equine encephalitis viruses.
    Jonsson CB; Cao X; Lee J; Gabbard JD; Chu YK; Fitzpatrick EA; Julander J; Chung DH; Stabenow J; Golden JE
    Antiviral Res; 2019 Jul; 167():25-34. PubMed ID: 30970271
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The transcriptional landscape of Venezuelan equine encephalitis virus (TC-83) infection.
    Yao Z; Zanini F; Kumar S; Karim M; Saul S; Bhalla N; Panpradist N; Muniz A; Narayanan A; Quake SR; Einav S
    PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009306. PubMed ID: 33788849
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Novel DNA-launched Venezuelan equine encephalitis virus vaccine with rearranged genome.
    Tretyakova I; Tibbens A; Jokinen JD; Johnson DM; Lukashevich IS; Pushko P
    Vaccine; 2019 May; 37(25):3317-3325. PubMed ID: 31072736
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A Monovalent and Trivalent MVA-Based Vaccine Completely Protects Mice Against Lethal Venezuelan, Western, and Eastern Equine Encephalitis Virus Aerosol Challenge.
    Henning L; Endt K; Steigerwald R; Anderson M; Volkmann A
    Front Immunol; 2020; 11():598847. PubMed ID: 33542715
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Human cathelicidin peptide LL-37 as a therapeutic antiviral targeting Venezuelan equine encephalitis virus infections.
    Ahmed A; Siman-Tov G; Keck F; Kortchak S; Bakovic A; Risner K; Lu TK; Bhalla N; de la Fuente-Nunez C; Narayanan A
    Antiviral Res; 2019 Apr; 164():61-69. PubMed ID: 30738837
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Entry Sites of Venezuelan and Western Equine Encephalitis Viruses in the Mouse Central Nervous System following Peripheral Infection.
    Phillips AT; Rico AB; Stauft CB; Hammond SL; Aboellail TA; Tjalkens RB; Olson KE
    J Virol; 2016 Jun; 90(12):5785-96. PubMed ID: 27053560
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Proteomic Discovery of VEEV E2-Host Partner Interactions Identifies GRP78 Inhibitor HA15 as a Potential Therapeutic for Alphavirus Infections.
    Barrera MD; Callahan V; Akhrymuk I; Bhalla N; Zhou W; Campbell C; Narayanan A; Kehn-Hall K
    Pathogens; 2021 Mar; 10(3):. PubMed ID: 33801554
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pegylated alpha interferon is an effective treatment for virulent venezuelan equine encephalitis virus and has profound effects on the host immune response to infection.
    Lukaszewski RA; Brooks TJ
    J Virol; 2000 Jun; 74(11):5006-15. PubMed ID: 10799574
    [TBL] [Abstract][Full Text] [Related]  

  • 60. β-d-
    Urakova N; Kuznetsova V; Crossman DK; Sokratian A; Guthrie DB; Kolykhalov AA; Lockwood MA; Natchus MG; Crowley MR; Painter GR; Frolova EI; Frolov I
    J Virol; 2018 Feb; 92(3):. PubMed ID: 29167335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.